NET PROFIT (x1000 NOK)
EMPLOYEES
Biomediq A/S
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-103
|
-87
|
-34 |
| Total assets |
64
|
179
|
320 |
| Current assets |
64
|
179
|
320 |
| Current liabilities |
67
|
71
|
75 |
| Equity capital |
-3
|
81
|
160 |
| - share capital |
635
|
603
|
566 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-4.7%
|
45.3%
|
50.0% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
95.5%
|
252.1%
|
426.7% |
| Return on equity (ROE) |
3433.3%
|
-107.4%
|
-21.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.